BMF-500, an investigational third-generation covalent FLT3 inhibitor, has shown preclinically to be possibly the most potent and selective inhibitor of FLT3 studied to date: Greater
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents
Under Florida’s no-fault system, your PIP pays medical bills (typically 80%) and lost wages (about 60%) after a crash, regardless of fault, but prompt action is crucial. Get treatment within